a:head bio AG
Facts
- Founded
- 2019
- Staff
- 9
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.
Similar companies in RDM biotech/pharma
EVER Neuro Pharma GmbH
- Organization type
- RDM biotech/pharma
- Region
- Upper Austria
- Focus
- human health
Evercyte GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
Gebro Pharma GmbH
- Organization type
- RDM biotech/pharma
- Region
- Tyrol
- Focus
- human health
Valdospan GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Focus
- human health
Contact
Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna
Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website